RS

Rakesh Sangwan

Director Director DIN 00882843
DIN 00882843 First appointment Jan 2007 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jan 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Rakesh Sangwan

Data last updated:

Rakesh Sangwan was a Director at Axiom Pharma Private Limited (2009–2017) and Director at Axiom Pharmaceuticals Private Limited (from 2007). The companies operate in Business Services.

DIN 00882843
Primary Designation Director
Industry Business Services
First Appointment 10 Jan 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Axiom Pharma Private Limited U24232RJ2009PTC029780
Director03 Sep 20092009₹2.81 Cr (FY 2025)Active
Director10 Jan 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Axiom Pharmaceuticals Private Limited
Axiom Pharma Private Limited
Premium access

Shareholding and investment profile for Rakesh Sangwan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Sangwan

Rakesh Sangwan was first appointed on 10 Jan 2007 as Director at Axiom Pharmaceuticals Private Limited. The most recent appointment on record is 03 Sep 2009 at Axiom Pharma Private Limited.

Rakesh Sangwan held 2 earlier board appointments: Axiom Pharma Private Limited (Director, 03 Sep 2009 to 28 Jul 2017); Axiom Pharmaceuticals Private Limited (Director, from 10 Jan 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available